[Analysis of homologous recombination deficiency testing in ovarian cancer based on next-generation sequencing]
{{output}}
Objective: To comprehensively evaluate homologous recombination deficiency (HRD) status via next-generation sequencing (NGS) in ovarian cancer patients and analyze its correlations with clinicopathological features, microsatellite instability (MSI), and tumor ... ...
